Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (Apeced)
1 clinical trials · Condition
◉ Watch Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (Apeced)
| Record | Firm | Date |
|---|---|---|
| Evaluate the Efficacy and Safety of Ruxolitinib on Hair Regrowth in Patients With Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED)-Associated Alopecia Areata (NCT05398809) | National Institute of Allergy and Infectious Diseases (NIAID) | 2023-01-18 |
Track Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (Apeced) automatically
Every clearance here is in the API, with alerts when new ones post.